Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-27

Clinical Trial Update: Lifitegrast Eye Drops in Healthy Subjects:Phase I Study [Phase 1]

View source ↗

Summary

A Phase I trial evaluating lifitegrast eye drops in healthy volunteers has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lifitegrast (lifitegrast)

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Dry Eye Syndromes | Phase 1 | Status: COMPLETED